JPRN-UMIN000032981已完成1 期
A clinical study on the safety of dendritic cell vaccine pulsed with neoantigen peptides for malignant tumor. - A clinical study on the safety of dendritic cell vaccine pulsed with neoantigen peptides for malignant tumor.
KOUSHIKAI,Non-profitmedicalcorporation0 个研究点目标入组 5 人开始时间: 2018年8月31日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •A patient MUST NOT: 1)Be apparent from the clinical manifestation of pulmonary fibrosis or interstitial pneumonia. 2)Have a history of a serious drug allergy. 3)Have a positive result of HIV antibody. 4)Have a serious cardiac disorder. 5)Have an active autoimmune disorder. 6)Have a concurrent cancer. 7)Have an infectious disorder that is difficult to control. 8)Be a female who is pregnant, lactating, or with a possibility of pregnancy.
研究者
相似试验
已完成
1 期
Dendritic cell immunotherapy in hepatitis C virus (HCV)-infected individuals.ACTRN12611001134910Eric J Gowans6
招募中
不适用
Clinical trial evaluating dendritic cell vaccination as an adjuvant immunotherapy in patients with pancreatic cancerPancreatic cancerJPRN-UMIN000009994Yokohama City University, Gastroenterological Surgery20
招募中
1 期
DC vaccine with neoantigen for malignant tumor.malignant tumorJPRN-jRCTc030190182Takimoto Rishu60
已完成
1 期
Clinical study of Dendritic Cell Vaccine in patients with Gastroenterological Cancer and Hepato-Biliary-Pancreatic Cancer.Esophageal cancer, Stomach cancer, Colon cancer, HCC, ICC, Bile duct cancer, pancreatic cancerJPRN-UMIN000005820Department of Gastroenterological Surgery, Tokyo Women's Medical University100
已完成
不适用
Clinical study of dendritic cell vaccine combined with transarterial embolization for patients with hepatocellular carcinomahepatocellular carcinomaJPRN-UMIN000012702Faculty of Medical Sciences, University of Fukui3